Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
ECYT > SEC Filings for ECYT > Form 8-K on 15-Oct-2012All Recent SEC Filings

Show all filings for ENDOCYTE INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ENDOCYTE INC

15-Oct-2012

Other Events


Item 8.01 Other Events.

Janssen Products, LP notified health care providers today that full access to DOXIL® (doxorubicin HCl liposome injection) supply is now available. The letter is posted on the website www.doxilsupply.com. Endocyte notes that:

• Endocyte's execution of the phase 3 PROCEED trial in platinum resistant ovarian cancer is not affected by this announcement; as previously announced, Endocyte had already secured sufficient supply of DOXIL® to bridge to the newly manufactured product.

• In this letter, Janssen describes the full access as the first step in a systematic approach to return to a dependable supply of DOXIL® using the remainder of its allocation program reserve. Janssen anticipates seamlessly bridging to its newly manufactured product in the near future.

• The Janssen Products manufacturing solution to deliver newly manufactured product is currently under expedited review by the FDA.

Top of the Form

  Add ECYT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ECYT - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.